Daewon Pharmaceutical Statistics

Total Valuation

KRX:003220 has a market cap or net worth of KRW 309.93 billion. The enterprise value is 438.56 billion.

Market Cap	309.93B
Enterprise Value	438.56B

Important Dates

The next estimated earnings date is Friday, March 14, 2025.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

KRX:003220 has 21.43 million shares outstanding. The number of shares has increased by 0.14% in one year.

Current Share Class	n/a
Shares Outstanding	21.43M
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	+2.19%
Owned by Insiders (%)	38.80%
Owned by Institutions (%)	12.96%
Float	12.84M

Valuation Ratios

The trailing PE ratio is 19.12 and the forward PE ratio is 7.39. KRX:003220's PEG ratio is 0.41.

PE Ratio	19.12
Forward PE	7.39
PS Ratio	0.52
PB Ratio	1.11
P/TBV Ratio	1.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	0.41

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.55, with an EV/FCF ratio of -31.41.

EV / Earnings	27.38
EV / Sales	0.74
EV / EBITDA	8.55
EV / EBIT	13.87
EV / FCF	-31.41

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.65.

Current Ratio	1.27
Quick Ratio	0.69
Debt / Equity	0.65
Debt / EBITDA	3.74
Debt / FCF	-13.59
Interest Coverage	3.59

Financial Efficiency

Return on equity (ROE) is 4.69% and return on invested capital (ROIC) is 4.49%.

Return on Equity (ROE)	4.69%
Return on Assets (ROA)	3.61%
Return on Invested Capital (ROIC)	4.49%
Return on Capital Employed (ROCE)	7.97%
Revenue Per Employee	471.38M
Profits Per Employee	12.71M
Employee Count	1,260
Asset Turnover	1.10
Inventory Turnover	2.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.34% in the last 52 weeks. The beta is 0.40, so KRX:003220's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-3.34%
50-Day Moving Average	14,429.20
200-Day Moving Average	14,809.70
Relative Strength Index (RSI)	50.53
Average Volume (20 Days)	82,703

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:003220 had revenue of KRW 593.94 billion and earned 16.02 billion in profits. Earnings per share was 756.15.

Revenue	593.94B
Gross Profit	288.61B
Operating Income	31.09B
Pretax Income	19.15B
Net Income	16.02B
EBITDA	50.75B
EBIT	31.09B
Earnings Per Share (EPS)	756.15

Full Income Statement

Balance Sheet

The company has 71.78 billion in cash and 189.73 billion in debt, giving a net cash position of -117.95 billion or -5,503.12 per share.

Cash & Cash Equivalents	71.78B
Total Debt	189.73B
Net Cash	-117.95B
Net Cash Per Share	-5,503.12
Equity (Book Value)	289.71B
Book Value Per Share	13,018.52
Working Capital	55.45B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 23.97 billion and capital expenditures -37.94 billion, giving a free cash flow of -13.96 billion.

Operating Cash Flow	23.97B
Capital Expenditures	-37.94B
Free Cash Flow	-13.96B
FCF Per Share	-651.45

Full Cash Flow Statement

Margins

Gross margin is 48.59%, with operating and profit margins of 5.23% and 2.70%.

Gross Margin	48.59%
Operating Margin	5.23%
Pretax Margin	3.22%
Profit Margin	2.70%
EBITDA Margin	8.54%
EBIT Margin	5.23%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 2.07%.

Dividend Per Share	300.00
Dividend Yield	2.07%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	39.70%
Buyback Yield	-0.14%
Shareholder Yield	1.93%
Earnings Yield	5.17%
FCF Yield	-4.51%

Dividend Details

Stock Splits

The last stock split was on March 7, 2022. It was a forward split with a ratio of 1.03.

Last Split Date	Mar 7, 2022
Split Type	Forward
Split Ratio	1.03

Scores

KRX:003220 has an Altman Z-Score of 2.52. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.52
Piotroski F-Score	n/a